No Increased Risk of Early Death With GH Therapy for Most Diagnostic Groups No Increased Risk of Early Death With GH Therapy for Most Diagnostic Groups

There doesn ' t appear to be an elevated risk of early death in children treated with growth hormone (GH) for idiopathic growth hormone deficiency (GHD), idiopathic short stature, small-for-gestational age (SGA), Turner syndrome, SHOX deficiency or history of benign neoplasia, compared with children in the general population.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Diabetes & Endocrinology News Source Type: news